🇺🇸 FDA
Company

Arcturus

Arcturus Therapeutics Holdings

ARCT pharma USA

Quick answer

Arcturus is a pharma company (ARCT) headquartered in SAN DIEGO, CA, USA with 12 tracked pipeline programs.

Pipeline (12)

project

ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine

COVID-19 Vaccines

Phase 3 · mab · completed

1 trials project

ARCT-2303

COVID-19

Phase 3 · mab · completed

1 trials project

ARCT-021

SARS-CoV-2

Phase 2 · mab · terminated

1 trials project

ARCT-021 Dose 1

SARS-CoV-2

Phase 2 · mab · completed

1 trials project

ARCT-021 single dose priming

Covid19

Phase 2 · mab · terminated

1 trials project

ARCT-032

Cystic Fibrosis

Phase 2 · small_molecule · active

2 trials project

ARCT-165

COVID-19

Phase 2 · mab · completed

1 trials project

ARCT-810

OTC Deficiency

Phase 2 · mab · active

1 trials project

ARCT-810

Ornithine Transcarbamylase Deficiency

Phase 2 · mab · completed

3 trials project

SARS-CoV-2 mRNA Vaccine ARCT-021

Hematopoietic and Lymphatic System Neoplasm

Phase 2 · mab · active

1 trials project

ARCT-2138

Influenza, Human

Phase 1 · mab · completed

1 trials project

ARCT-2304

Influenza, Human

Phase 1 · mab · completed

1 trials

Patents (8)

patent

US 12398379

Compositions and methods for treating ornithine transcarbamylase deficiency

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12390524

Compositions and methods for inducing immune responses

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12351834

Compositions and methods for the treatment of ornithine transcarbamylase deficie

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12290567

Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugat

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12286395

Method of synthesis of an ionizable cationic lipid

Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12220455

Coronavirus vaccine compositions and methods

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12220485

Method of making lipid-encapsulated RNA nanoparticles

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12178921

Method of lyophilizing lipid nanoparticles

Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)